Literature DB >> 21460582

A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.

Lura Abbott1, Christine Grady.   

Abstract

Institutional review boards (IRBs) are integral to the U.S. system of protection of human research participants. Evaluation of IRBs, although difficult, is essential. To date, no systematic review of IRB studies has been published. We conducted a systematic review of empirical studies of U.S. IRBs to determine what is known about the function of IRBs and to identify gaps in knowledge. A structured search in PubMed identified forty-three empirical studies evaluating U.S. IRBs. Studies were included if they reported an empirical investigation of the structure, process, outcomes, effectiveness, or variation of U.S. IRBs. The authors reviewed each study to extract information about study objectives, sample and methods, study results, and conclusions. Empirical evidence collected in forty-three published studies shows that for review of a wide range of types of research, U.S. IRBs differ in their application of the federal regulations, in the time they take to review studies, and in the decisions made. Existing studies show evidence of variation in multicenter review, inconsistent or ambiguous interpretation of the federal regulations, and inefficiencies in review. Despite recognition of a need to evaluate effectiveness of IRB review, no identified published study included an evaluation of IRB effectiveness. Multiple studies evaluating the structure, process, and outcome of IRB review in the United States have documented inconsistencies and inefficiencies. Efforts should be made to address these concerns. Additional research is needed to understand how IRBs accomplish their objectives, what issues they find important, what quality IRB review is, and how effective IRBs are at protecting human research participants.

Entities:  

Mesh:

Year:  2011        PMID: 21460582      PMCID: PMC3235475          DOI: 10.1525/jer.2011.6.1.3

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  55 in total

1.  Improving protection for research subjects.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

2.  Variation in institutional review board responses to a standard protocol for a multicenter clinical trial.

Authors:  T O Stair; C R Reed; M S Radeos; G Koski; C A Camargo
Journal:  Acad Emerg Med       Date:  2001-06       Impact factor: 3.451

3.  Inconsistency and IRBs: flaws in the Goldman-Katz study.

Authors:  Robert J Levine; Martin D Katz; Jerry Goldman
Journal:  IRB       Date:  1984 Jan-Feb

4.  A survey of university institutional review boards: characteristics, policies, and procedures.

Authors:  Gregory J Hayes; Steven C Hayes; Thane Dykstra
Journal:  IRB       Date:  1995 May-Jun

5.  A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs.

Authors:  Audrey Smith Rogers; Donald F Schwartz; Gloria Weissman; Abigail English
Journal:  IRB       Date:  1999 Jan-Feb

6.  Federal report says protection of human subjects is threatened by numerous factors.

Authors:  Dennis M Maloney
Journal:  Hum Res Rep       Date:  1996-05

7.  Variability in institutional review board assessment of minimal-risk research.

Authors:  Jon Mark Hirshon; Scott D Krugman; Michael D Witting; Jon P Furuno; M Rhona Limcangco; Andre R Perisse; Elizabeth K Rasch
Journal:  Acad Emerg Med       Date:  2002-12       Impact factor: 3.451

8.  Variability among institutional review boards' decisions within the context of a multicenter trial.

Authors:  H Silverman; S C Hull; J Sugarman
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

9.  The roles and experiences of nonaffiliated and non-scientist members of institutional review boards.

Authors:  Sohini Sengupta; Bernard Lo
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

10.  Breaking the camel's back: multicenter clinical trials and local institutional review boards.

Authors:  W J Burman; R R Reves; D L Cohn; R T Schooley
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

View more
  64 in total

1.  Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects.

Authors:  David L Evers; Carol B Fowler; Jeffrey T Mason; Rebecca K Mimnall
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

2.  Addressing risks to advance mental health research.

Authors:  Ana S Iltis; Sahana Misra; Laura B Dunn; Gregory K Brown; Amy Campbell; Sarah A Earll; Anne Glowinski; Whitney B Hadley; Ronald Pies; James M Dubois
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

3.  Operational Characteristics of Institutional Review Boards (IRBs) in the United States.

Authors:  Genevieve L Nesom; Iraklis Petrof; Tyler M Moore
Journal:  AJOB Empir Bioeth       Date:  2019-10-16

4.  Challenges to Studying Illicit Drug Users.

Authors:  Jennie E Ryan; Suzanne C Smeltzer; Nancy C Sharts-Hopko
Journal:  J Nurs Scholarsh       Date:  2019-05-20       Impact factor: 3.176

Review 5.  Institutional Review Boards: Purpose and Challenges.

Authors:  Christine Grady
Journal:  Chest       Date:  2015-11       Impact factor: 9.410

6.  Community-Based Review of Research Across Diverse Community Contexts: Key Characteristics, Critical Issues, and Future Directions.

Authors:  Nancy Shore; Angela Ford; Eric Wat; Missy Brayboy; Mei-Ling Isaacs; Alice Park; Hal Strelnick; Sarena D Seifer
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

7.  A Measure of Effectiveness Is Key to the Success of sIRB Policy.

Authors:  Holly A Taylor; Ann Margret Ervin
Journal:  Am J Bioeth       Date:  2017-07       Impact factor: 11.229

8.  Human Participants in Engineering Research: Notes from a Fledgling Ethics Committee.

Authors:  David Koepsell; Willem-Paul Brinkman; Sylvia Pont
Journal:  Sci Eng Ethics       Date:  2014-06-18       Impact factor: 3.525

9.  Barriers to Effective Deliberation in Clinical Research Oversight.

Authors:  Danielle M Wenner
Journal:  HEC Forum       Date:  2016-09

10.  Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?

Authors:  Kristen Underhill
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.